Dabigatran versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine - Tập 361 Số 12 - Trang 1139-1151 - 2009
Stuart J. Connolly1, Michael D. Ezekowitz2, Salim Yusuf1, John W. Eikelboom1, Jonas Oldgren3, Amit Parekh2, Janice Pogue1, Paul Reilly4, Ellison Themeles1, Jeanne Varrone4, Susan Wang4, Marco Alings5, Denis Xavier6, Jun Zhu7, Rafael Díaz8, Basil S. Lewis9, Harald Darius10, Hans‐Christoph Diener11,10, Campbell Joyner12, Lars Wallentin3
1Population Health Research Institute, McMaster University, and Hamilton Health Sciences, Hamilton, ON, Canada
2Lankenau Institute for Medical Research and the Heart Center, Wynnewood, PA
3Uppsala Clinical Research Center, Uppsala, Sweden
4Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT
5Working Group on Cardiovascular Research The Netherlands, Utrecht, The Netherlands
6St. John’s National Academy of Health Sciences, Bangalore, India
7Fuwai Hospital, Beijing
8Estudios Clínicos Latinoamérica, Rosario, Argentina
9Lady Davis Carmel Medical Center, Haifa, Israel
10Vivantes Klinikum Neukölln, Berlin
11University Duisburg-Essen, Essen, Germany
12Sunnybrook Health Sciences Centre, Toronto

Tóm tắt

Từ khóa


Tài liệu tham khảo

Hart RG, 2007, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007

10.1016/j.jacc.2006.07.009

10.1161/01.STR.0000208294.46968.a4

10.1161/CIRCULATIONAHA.106.653048

10.1161/CIRCULATIONAHA.107.750000

10.2165/00003088-200847050-00001

10.1016/j.amjcard.2007.06.034

10.1016/S0140-6736(07)61445-7

10.1016/j.ahj.2009.02.005

Rosendaal FR, 1993, Thromb Haemost, 69, 236, 10.1055/s-0038-1651587

Hart RG, 1999, Ann Intern Med, 131, 492, 10.7326/0003-4819-131-7-199910050-00003

10.1001/jama.285.22.2864

10.1056/NEJMoa0901301

10.1016/S0140-6736(06)68845-4

10.1016/S0140-6736(08)60168-3

10.1159/000091265

10.1056/NEJMoa020496